In glioma, the increase in T cell activation markers was concomitant with reduced levels of the exhaustion markers PD-1 and CTLA-4 involved in T cell suppression; the KD also decreased the expression of the respective ligand on the tumor cells, PDL-1, thereby hampering tumor-induced T cell inhibition [20]. Here, CTLA4 is linked to neoplasm.